RU95106821A - Циклопептиды, способ их получения, фармацевтическая композиция и способ ее получения - Google Patents
Циклопептиды, способ их получения, фармацевтическая композиция и способ ее полученияInfo
- Publication number
- RU95106821A RU95106821A RU95106821/04A RU95106821A RU95106821A RU 95106821 A RU95106821 A RU 95106821A RU 95106821/04 A RU95106821/04 A RU 95106821/04A RU 95106821 A RU95106821 A RU 95106821A RU 95106821 A RU95106821 A RU 95106821A
- Authority
- RU
- Russia
- Prior art keywords
- synthesis
- treatment
- cyclopeptides
- preparing
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/75—Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/52—Cyclic peptides containing at least one abnormal peptide link with only normal peptide links in the ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/27—Cyclic peptide or cyclic protein
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Zoology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Toxicology (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Изобретение касается новых циклопептидов формулы I цикло-(Arg-A-Asp-R-R), где A, Rи Rимеют значения, указанные в п.1 формулы изобретения, а также их солей. Эти соединения действуют как ингибиторы интегрина и могут быть применены, в частности, для профилактики и лечения заболеваний кровообращения, костей и противоопухолевой терапии, а также как антимикробные и антивирусные активные вещества.
Claims (1)
- Изобретение касается новых циклопептидов формулы I цикло-(Arg-A-Asp-R1-R2), где A, R1 и R2 имеют значения, указанные в п.1 формулы изобретения, а также их солей. Эти соединения действуют как ингибиторы интегрина и могут быть применены, в частности, для профилактики и лечения заболеваний кровообращения, костей и противоопухолевой терапии, а также как антимикробные и антивирусные активные вещества.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4415310A DE4415310A1 (de) | 1994-04-30 | 1994-04-30 | Cyclopeptide |
| DEP4415310.4 | 1994-04-30 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU95106821A true RU95106821A (ru) | 1997-01-10 |
| RU2151776C1 RU2151776C1 (ru) | 2000-06-27 |
Family
ID=6516993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU95106821/04A RU2151776C1 (ru) | 1994-04-30 | 1995-04-27 | Циклопептиды, способ их получения |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5693612A (ru) |
| EP (1) | EP0683173B1 (ru) |
| JP (1) | JP3711154B2 (ru) |
| KR (1) | KR100360831B1 (ru) |
| CN (1) | CN1161374C (ru) |
| AT (1) | ATE183199T1 (ru) |
| AU (1) | AU697614B2 (ru) |
| CA (1) | CA2148194C (ru) |
| CZ (1) | CZ286705B6 (ru) |
| DE (2) | DE4415310A1 (ru) |
| DK (1) | DK0683173T3 (ru) |
| ES (1) | ES2137394T3 (ru) |
| GR (1) | GR3031696T3 (ru) |
| HU (1) | HU216795B (ru) |
| NO (1) | NO311892B1 (ru) |
| PL (1) | PL181272B1 (ru) |
| RU (1) | RU2151776C1 (ru) |
| SK (1) | SK281843B6 (ru) |
| TW (1) | TW354790B (ru) |
| UA (1) | UA46699C2 (ru) |
| ZA (1) | ZA953467B (ru) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7244622B2 (en) * | 1996-04-03 | 2007-07-17 | Applera Corporation | Device and method for multiple analyte detection |
| DE19736772A1 (de) * | 1997-08-23 | 1999-02-25 | Merck Patent Gmbh | Cyclopeptidderivate |
| WO2000038730A2 (en) | 1998-12-23 | 2000-07-06 | G.D. Searle & Co. | Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia |
| MXPA03007878A (es) * | 2001-03-02 | 2004-07-08 | Medimmune Inc | Metodos de prevencion o tratamiento de alteraciones inflamatorias o autoinmunes mediante la administracion de los antagonistas alfav, beta3 de integrina. |
| WO2003075741A2 (en) * | 2002-03-04 | 2003-09-18 | Medimmune, Inc. | METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE |
| CA2478239A1 (en) * | 2002-03-04 | 2003-09-18 | Medimmune, Inc. | The prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents |
| AU2003226065B2 (en) * | 2002-04-12 | 2009-02-26 | Ludwig Institute For Cancer Research, Ltd | Recombinant anti-interleukin-9 antibodies |
| AU2004207002A1 (en) * | 2003-01-30 | 2004-08-12 | Medimmune, Inc. | Uses of integrin alphavbeta3 antagonists |
| KR20120035234A (ko) * | 2003-04-11 | 2012-04-13 | 메디뮨 엘엘씨 | 재조합 ｉｌ?９ 항체 및 그의 용도 |
| CN100429223C (zh) * | 2004-02-06 | 2008-10-29 | 南京工业大学 | 环(d-苯丙-d-组)二肽的制备方法 |
| US7351739B2 (en) * | 2004-04-30 | 2008-04-01 | Wellgen, Inc. | Bioactive compounds and methods of uses thereof |
| KR101224368B1 (ko) | 2004-06-04 | 2013-01-22 | 더 스크립스 리서치 인스티튜트 | 혈관신생 질환 치료용 조성물 및 방법 |
| JP2008516979A (ja) * | 2004-10-14 | 2008-05-22 | リゲル ファーマシューティカルズ インコーポレーティッド | Ｉｒｅｓ仲介性翻訳の複素環式阻害剤およびその使用法 |
| EP2422811A2 (en) | 2004-10-27 | 2012-02-29 | MedImmune, LLC | Modulation of antibody specificity by tailoring the affinity to cognate antigens |
| WO2006048473A1 (es) * | 2004-10-30 | 2006-05-11 | Universidad Del Pais Vasco/Euskal Herriko Unibertsitatea | CICLOPÉPTIDOS RGD β-LACTÁMINOS GIROS GAMMA (Ϝ) |
| EP2043603A4 (en) | 2006-07-11 | 2010-10-27 | Arubor Corp | PREVENTION AND THERAPY OF RHINOSINUSITIS WITH PROINFLAMMATORY CYTOKINHERMERS |
| HUE048024T2 (hu) | 2006-08-10 | 2020-05-28 | Roy C Levitt | Anakinra bronchiolitis obliterans szindróma kezelésében való alkalmazásra |
| WO2010105363A1 (en) | 2009-03-16 | 2010-09-23 | Andrei Yudin | Cyclic amino acid molecules and methods of preparing the same |
| CA2998968C (en) * | 2015-09-18 | 2024-03-19 | Technische Universitat Munchen | Ligands for integrin .alpha.v.beta.6, synthesis and uses thereof |
| KR20180095809A (ko) | 2015-11-11 | 2018-08-28 | 인사이클 세라퓨틱스, 인코포레이티드 | α4β7 인테그린을 표적으로 하는 고리형 펩타이드 |
| ES2884107T3 (es) | 2016-11-11 | 2021-12-10 | Zealand Pharma As | Multímeros de péptidos cíclicos con diana en la integrina alfa-4 beta-7 |
| EP3388445A1 (en) * | 2017-04-10 | 2018-10-17 | F. Hoffmann-La Roche AG | Peptide macrocycles and use thereof in the treatment of bacterial infections |
| CA3062385A1 (en) | 2017-05-10 | 2018-11-15 | Encycle Therapeutics, Inc. | Homodetic cyclic peptides targeting a4s7 1ntegrin |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4472305A (en) * | 1983-05-17 | 1984-09-18 | Sterling Drug Inc. | Hexapeptide amides |
| JP2945680B2 (ja) * | 1988-09-09 | 1999-09-06 | 旭硝子株式会社 | ペプチド誘導体およびその用途 |
| US5192746A (en) * | 1990-07-09 | 1993-03-09 | Tanabe Seiyaku Co., Ltd. | Cyclic cell adhesion modulation compounds |
| AU666853B2 (en) * | 1991-04-05 | 1996-02-29 | Genentech Inc. | Platelet aggregation inhibitors having high specificity for GP IIbIIIa |
| IL103252A (en) * | 1991-09-30 | 1997-03-18 | Du Pont Merck Pharma | CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| UA43823C2 (uk) * | 1992-07-06 | 2002-01-15 | Мерк Патент Геселлшафт Міт Бесшренктер Хафтунг | ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ДЛЯ ІНГІБУВАННЯ ІНТЕГРИН <font face="Symbol">a</font><sub>V</sub><font face="Symbol">b</font><sub>3</sub>-ОПОСЕРЕДКОВАНОЇ КЛІТИННОЇ АДГЕЗІЇ КЛІТИН ССАВЦІВ, СПОСІБ ЛІКУВАННЯ ТА ПРОФІЛАКТИКИ ЗАХВОРЮВАННЯ, АСОЦІЙОВАНОГО З ПОРУШЕННЯМ АДГЕЗІЇ КЛІТИН, СПОСІБ БЛОКУВАННЯ ЗВ'ЯЗУВАННЯ ФІБРИНОГЕНОМ ІНТЕГРИНУ, КОМПОЗИЦІЯ ДЛЯ ЗАГОЄННЯ РАН |
| DE4310643A1 (de) * | 1993-04-01 | 1994-10-06 | Merck Patent Gmbh | Cyclische Adhäsionsinhibitoren |
-
1994
- 1994-04-30 DE DE4415310A patent/DE4415310A1/de not_active Withdrawn
-
1995
- 1995-04-21 UA UA95048361A patent/UA46699C2/uk unknown
- 1995-04-26 DE DE59506568T patent/DE59506568D1/de not_active Expired - Lifetime
- 1995-04-26 DK DK95106259T patent/DK0683173T3/da active
- 1995-04-26 EP EP95106259A patent/EP0683173B1/de not_active Expired - Lifetime
- 1995-04-26 AT AT95106259T patent/ATE183199T1/de active
- 1995-04-26 CZ CZ19951073A patent/CZ286705B6/cs not_active IP Right Cessation
- 1995-04-26 ES ES95106259T patent/ES2137394T3/es not_active Expired - Lifetime
- 1995-04-27 RU RU95106821/04A patent/RU2151776C1/ru active
- 1995-04-27 TW TW084104188A patent/TW354790B/zh active
- 1995-04-27 AU AU17724/95A patent/AU697614B2/en not_active Expired
- 1995-04-28 ZA ZA953467A patent/ZA953467B/xx unknown
- 1995-04-28 PL PL95308420A patent/PL181272B1/pl not_active IP Right Cessation
- 1995-04-28 JP JP10665595A patent/JP3711154B2/ja not_active Expired - Lifetime
- 1995-04-28 NO NO19951645A patent/NO311892B1/no not_active IP Right Cessation
- 1995-04-28 HU HU9501253A patent/HU216795B/hu not_active IP Right Cessation
- 1995-04-28 KR KR1019950010234A patent/KR100360831B1/ko not_active IP Right Cessation
- 1995-04-28 SK SK558-95A patent/SK281843B6/sk unknown
- 1995-04-28 CA CA002148194A patent/CA2148194C/en not_active Expired - Lifetime
- 1995-04-28 US US08/430,238 patent/US5693612A/en not_active Expired - Lifetime
- 1995-04-28 CN CNB951052004A patent/CN1161374C/zh not_active Expired - Lifetime
-
1999
- 1999-11-03 GR GR990402787T patent/GR3031696T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2151776C1 (ru) | 2000-06-27 |
| DE4415310A1 (de) | 1995-11-02 |
| CA2148194C (en) | 2007-04-10 |
| PL181272B1 (pl) | 2001-07-31 |
| SK281843B6 (sk) | 2001-08-06 |
| ES2137394T3 (es) | 1999-12-16 |
| CN1161374C (zh) | 2004-08-11 |
| DK0683173T3 (da) | 2000-03-13 |
| HUT75057A (en) | 1997-03-28 |
| CZ286705B6 (en) | 2000-06-14 |
| CZ107395A3 (en) | 1995-11-15 |
| AU697614B2 (en) | 1998-10-15 |
| EP0683173A1 (de) | 1995-11-22 |
| PL308420A1 (en) | 1995-11-13 |
| KR950032275A (ko) | 1995-12-20 |
| UA46699C2 (uk) | 2002-06-17 |
| SK55895A3 (en) | 1995-12-06 |
| JP3711154B2 (ja) | 2005-10-26 |
| NO311892B1 (no) | 2002-02-11 |
| DE59506568D1 (de) | 1999-09-16 |
| NO951645D0 (no) | 1995-04-28 |
| HU216795B (hu) | 1999-08-30 |
| CN1116628A (zh) | 1996-02-14 |
| HU9501253D0 (en) | 1995-06-28 |
| TW354790B (en) | 1999-03-21 |
| NO951645L (no) | 1995-10-31 |
| ZA953467B (en) | 1996-01-17 |
| ATE183199T1 (de) | 1999-08-15 |
| CA2148194A1 (en) | 1995-10-31 |
| US5693612A (en) | 1997-12-02 |
| GR3031696T3 (en) | 2000-02-29 |
| JPH07304795A (ja) | 1995-11-21 |
| EP0683173B1 (de) | 1999-08-11 |
| KR100360831B1 (ko) | 2003-01-24 |
| AU1772495A (en) | 1995-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU95106821A (ru) | Циклопептиды, способ их получения, фармацевтическая композиция и способ ее получения | |
| RU95102778A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования потерь костной ткани и снижения уровня холестерина в сыворотке, фармацевтический препарат, содержащий 2-фенил-3-ароилбензотиофен | |
| BR9813373A (pt) | Composto, processo para a preparação do mesmo, composição farmacêutica, processo para a preparação da mesma, uso de um composto, e, processos para efetuar imunossupressão e para tratar ou reduzir o risco de uma doença das vias aérias obstrutiva reversìvel em um paciente | |
| RU94027680A (ru) | Паращитовидный гормон и ралоксифон для увеличения массы кости, фармацевтический состав и способ увеличения костной массы | |
| RU94036758A (ru) | Применение 2-фенил-3-ароилбензотиофенов для лечения пери-менопаузного синдрома | |
| RU94042907A (ru) | Производные имидазопиридина, способ их получения, фармацевтическая композиция и способ ее получения | |
| NO169291C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktivt tetrapyrrol-amino-dicarboxylsyreaddukt | |
| RU94022258A (ru) | Новые сульфониламинопиримидины | |
| BG106825A (en) | Substituted oxazolidinones and their use in the field of blood coagulation | |
| DE69713526D1 (de) | Lösliche prodrugs von paclitaxel | |
| RU94022743A (ru) | Амидо- или карбамидо-производные, обладающие антигиперхолестериновой активностью, и фармацевтическая композиция на их основе | |
| FI971951A0 (fi) | 2,2-dikloroalkaanikarboksyylihapot, menetelmät niiden valmistamiseksi, niitä sisältävät lääkkeet, ja niiden käyttö insuliiniresistanssin hoitoon | |
| RU94044456A (ru) | Средство для подавления дисфункционального маточного кровотечения | |
| RU95111308A (ru) | Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция | |
| BR9813318A (pt) | Processo de tratamento de tumores e degeneração macular em paciente humano ou veterinário, composição farmacêutica para tratamento de tumores e degeneração macular em um paciente humano ou veterinário | |
| DE69521536D1 (de) | Zusammensetzungen die G-CSF und ein TNF-Bindungsprotein enthalten | |
| RU94045271A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера | |
| ATE161725T1 (de) | Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina | |
| NZ324380A (en) | Therapeutic benzimidazole compounds and their use in treatment of virus infections | |
| ATE192923T1 (de) | Verwendung von boswelliasäure zur behandlung von hirntumoren | |
| FR2500303B1 (ru) | ||
| RU94031479A (ru) | Новое применение производных аминокислот, способ лечения, фармацевтическая композиция | |
| EA200401295A1 (ru) | Статиновая терапия для усиления поддержания когнитивной функции | |
| RU95109874A (ru) | Гетероциклилоксибензоилгуанидины, способ их получения, содержащая их фармацевтическая композиция и способ ее получения | |
| RU94046312A (ru) | Применение биологически активных уреидопроизводных для лечения индуцируемых лентивирусами заболеваний, продукты, содержащие уреидопроизводные |